Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature

Atsushi Ono; Nicolas Goossens; Richard S Finn; Warren N Schmidt; Swan N Thung; Gene Y Im; Yujin Hoshida; Precision Liver Cancer Prevention Consortium

doi:10.1002/hep.29203

Back

Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature

Journal article

Open access

Peer reviewed

Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature

Atsushi Ono, Nicolas Goossens, Richard S Finn, Warren N Schmidt, Swan N Thung, Gene Y Im, Yujin Hoshida and Precision Liver Cancer Prevention Consortium

Hepatology (Baltimore, Md.), Vol.66(4), pp.1344-1346

10/2017

DOI: 10.1002/hep.29203

PMCID: PMC5605396

PMID: 28390144

Files and links (1)

url

https://doi.org/10.1002/hep.29203View

Published (Version of record) Open Access

Abstract

no abstract

Liver Neoplasms - epidemiology

Carcinoma, Hepatocellular - epidemiology

Carcinoma, Hepatocellular - complications

Risk Assessment

Humans

Middle Aged

Transcriptome

Liver Neoplasms - complications

Male

Hepatitis C, Chronic - complications

Hepatitis C, Chronic - drug therapy

Hepatitis C, Chronic - genetics

Details

Title: Subtitle: Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature
Creators: Atsushi Ono - Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
Nicolas Goossens - Division of Gastroenterology and Hepatology, Geneva University Hospital, Geneva, Switzerland
Richard S Finn - Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA
Warren N Schmidt - Department of Internal Medicine and Research Service, Veterans Affairs Medical Center, Department of Internal Medicine, Roy G. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA
Swan N Thung - Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY
Gene Y Im - Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
Yujin Hoshida - Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
Precision Liver Cancer Prevention Consortium
Resource Type: Journal article
Publication Details: Hepatology (Baltimore, Md.), Vol.66(4), pp.1344-1346
DOI: 10.1002/hep.29203
PMID: 28390144
PMCID: PMC5605396
ISSN: 0270-9139
eISSN: 1527-3350
Grant note: I01 BX000159 / BLRD VA R01 DK099558 / NIDDK NIH HHS P30 CA196521 / NCI NIH HHS S10 OD018522 / NIH HHS
Language: English
Date published: 10/2017
Academic Unit: Gastroenterology and Hepatology; Internal Medicine
Record Identifier: 9984094339502771

Metrics

12 Record Views

28 Times Cited - Web of Science

See more details